WANJIA GROUP (00401) announced its unaudited interim results for the six months ended September 30, 2025. The company recorded revenue of HK$85.706 million, representing a 2.4% year-on-year increase. However, it reported a loss attributable to shareholders of HK$712,000, compared to a profit of HK$1.256 million in the same period last year. Basic loss per share stood at HK$0.00127. The revenue growth was primarily driven by increased income from the hemodialysis business segment.